CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023
- Thursday, February 23, 2023, 7:12
- PR Newswire
- Add a comment
SEATTLE, Feb. 23, 2023 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that its fourth quarter and full year 2022 financial…
About the Author
admin has written 20652 stories on this site.